Interactive Clinical Discussion on XPOVIO

When

04/28/20    
6:00 pm - 8:00 pm

XPOVIO® (selinexor) The first and only FDA-approved oral selective nuclear export inhibitor in relapsed refractory multiple myeloma (RRMM)

Virtual Event through Adobe Connect

Presented by:
Joseph Mikhael, MD
Translational Genomics Research Institute (City of Hope)

To RSVP, please email KaryopharmRSVP@PW.Veeva.com or call 866-914-9069

Please Note: You will receive log-in/dial-in details once you are successfully registered

KAR0000856 Please reference this number during registration.

About us

The Silicon Valley chapter of the Oncology Nursing Society is committed to provide mechanisms to further the professional development of the individual members within the chapter.

A secondary but equally important mission is to provide an atmosphere of collegial, professional and emotional support to the chapter membership throughout the continued transition in health care as it exists in the state of California and as it evolves throughout the nation..

Contact Info

a 503c Organization, Santa Clara, CA, USA